Past Presidents

 

We hope you enjoy reading about the ATA Past Presidents.  These bios and photos were collected as part of the ATA’s Centennial Initiative.  To view a comprehensive ATA timeline and the Presidential Addresses/Reports that are in the archive, please visit the ATA Historical Timeline and click on the name of an ATA President to view their remarks (if available).

Special thanks to David S. Cooper, MD, Valerie Galton, PhD, Connie Trump, PharmD, and Caroline T. Nguyen, MD for their leadership of this effort.

E.P. Sloan

President, 1923 – 1925

Edwin Plummer SloanEdwin Plummer Sloan  Dr. Sloan was born in Missouri and graduated from medical school in 1898.  Following a surgical residency, he received additional training at clinics in Berlin, Germany.  Dr. Sloan founded and was the first president of the American Association for Study of Goiter.  The first meeting, with 215 registrants, took place on January 23-25, 1924 at St. Joseph’s Hospital in Bloomington, Illinois, where Dr. Sloan was on the surgical staff.  The first session was held by Dr. E. P. Sloan, assisted by Drs. G. A. Sloan, Herman Wellmerling, J. D. Moschelle, and Geo. Newell. Four patients were operated under nitrous oxide oxygen anaesthesia, administered by Dr. Wm. Young.  A number of scientific papers were also presented, including Dr. E. R. Arn, Dayton, Ohio. “An Analysis of Types of Goiter with Indications for Treatment.” and Dr. F. N. Wilson, Ann Arbor, Michigan. “Cardiac Disturbances in Association with Diseases of the Thyroid Gland.”

Dr. Sloan was the president of the Illinois State Medical Society, and at his death, was a member of the judicial council of the American Medical Association.

E.G. Blair

President, 1926

Edward Giles Blair Edward Giles Blair  Dr. Blair grew up in Atchison, Kansas and graduated from Kansas State University in 1887.  He then attended Columbia Medical School and surgical residency at Roosevelt Hospital in New York City.  He established an extensive surgical practice in Kansas City in 1894.  He taught anatomy at University of Missouri medical college and clinical surgery at the Women’s Medical College of Kansas City.  He was a pioneer in the development of plastic surgery and skin grafting.

Emil Goetsch

President, 1927

Emil GoetschEmil Goetsch  Dr. Goetsch was born in Iowa, attended the University of Chicago, and earned his MD degree at Johns Hopkins University School of Medicine in 1909.  He did a surgical residency under the direction of Dr. William Halstead, and also did additional training at the Peter Bent Brigham Hospital in Boston under Dr. Harvey Cushing.  He returned to Johns Hopkins and became an Associate Professor of Surgery in 1918.  He then moved to New York to become a Professor of Surgery at Long Island College of Medicine in Brooklyn, which later merged with the State University of New York Downstate School of Medicine.  He had a long-standing interest in thyroid surgery, and published numerous papers on thyroid disease. He was one of the first to describe the relationship of autonomous thyroid nodules as a cause of hyperthyroidism in 1918, and in a 1987 review article, the author suggested that thyrotoxicosis due to functioning thyroid nodules be called “Goetsch’s disease”.

Gordon S. Fahrni

President, 1928

Gordon S. FahrniGordon S. Fahrni  Dr. Fahrni was born in near Winnipeg Manitoba, Canada and attended Wesley College in Winnipeg before entering medical school at the University of Manitoba.  After his surgical residency at Winnipeg General Hospital, he served with the Canadian Army Medical Corps.  He returned to Winnipeg after the war, opened a surgical practice there, and taught at the University of Manitoba.  Dr. Fahrni was acknowledged as a North American expert on goiter surgery and as a pioneer in the use of local anesthetic in thyroid surgery.  He published many papers on thyroid disease and thyroid surgery. He was a founding member of the American Association for the Study of Goiter.  In 1941, Dr. Fahrni became the President of the Canadian Medical Association.  He published an autobiography, Prairie Surgeon, in 1947.

S.D. Van Meter

President, 1929

Seymour D. Van Meter Seymour D. Van Meter  Dr. Van Meter was from Texas and attended the University of Pennsylvania School of Medicine, graduating in 1889.  After residency training in Philadelphia, Dr. Van Meter established a surgical practice in Denver, Colorado in the early 1890’s.  His daughter, Virginia Van Meter, was the first female surgeon in Colorado.  Both he and Virginia Van Meter were founding members of the American Association for the Study of Goiter (AASG).  He chaired an AASG committee on Goiter Classification and Nomenclature, publishing an influential report in 1929.  According to this schema, goiters were stated to be either diffuse or nodular and, within those categories, nontoxic or toxic.  In 1930, and annually for several more years, he donated funds to support an award for the best essay on the subject of “Goiter—Especially Its Basic Cause”, which has evolved into the current Van Meter Prize, one of the ATA’s most prestigious honors.

A.R. Arn

President, 1930

Elmer Raymond ArnElmer Raymond Arn   Dr. Arn was born in Ohio and attended Miami University of Ohio before earning his medical degree at the University of Cincinnati medical school in 1911.  He did a surgical residency at Miami Valley Hospital in Dayton, Ohio, and also studied surgery in Germany and Switzerland.  Dr. Arn was one of the founders of the American Association for the Study of Goiter.  He was a member of the board of governors of the American College of Surgeons, and was known as the “Dean of Dayton surgeons” at the time of his death.

Kerwin Kinard

President, 1931

Kerwin Weidman Kinard Kerwin Weidman Kinard  Dr. Kinard was born in Philadelphia and graduated from the University of Pennsylvania School of Medicine in 1908.  He did his residency at Lankenau Hospital in Philadelphia, he had additional surgical training at the University of Berlin.  After serving in the U.S. Army Medical Corps in World War I, he established a surgical practice in Kansas City, Missouri, where he became a renowned thyroid surgeon.  He subsequently returned to Philadelphia, and at the time of his death was the Director of Tuberculosis Control for the Pennsylvania Department of Health.

M.O. Shivers

President, 1932

Marcus O. Shivers, PhD., MDMarcus O. Shivers, PhD., MD  Dr. Shivers was a native of Mississippi.  He earned his MD degree in 1900 at the University of the South in Sewanee, Tennessee.  He had additional surgical training at the New York Polyclinic School and Europe, and was a surgical resident at the Charity Hospital in Vicksburg, MS.  He subsequently established a surgical practice in Colorado Springs, Colorado, specializing in thyroid surgery, and became a Professor of Surgery at St. Francis Hospital Training School in that city.  He was a representative to the 1927 International Goiter Conference in Berne, Switzerland.

Henry S. Plummer

President, 1933

Henry Stanley PlummerHenry Stanley Plummer  Dr. Plummer graduated from Northwestern University Medical School in 1898, and returned home to Minnesota to practice medicine with his father.  He was recruited to join the relatively new Mayo Clinic in 1901.  He became an authority on thyroid disease, but was also known for organizing patient care at the Mayo Clinic: he created the first example of the modern patient medical record giving each patient a unique ID.  He invented the pneumatic tube system to transfer medical records from the central storage area to a specific office.  He also pioneered the model of the integrated multi specialty group practice at the Mayo Clinic, now used throughout the world.

R.M. Howard

President, 1934

Dr. Robert Mayburn HowardRobert Mayburn Howard  Dr. Howard grew up in Oklahoma, and graduated from the University of Michigan Medical School in 1901. He returned to Oklahoma, and became Professor of Surgery at the University of Oklahoma Medical School from 1934 to 1946.  He was Chief of Staff of St. Anthony’s Hospital in Oklahoma City, and was a Governor of the American College of Surgeons from 1939 to 1947.

Allen Graham

President, 1935

Allen GrahamAllen Graham  Dr. Graham graduated from the University of Florida in 1906 and from the University of Maryland School of Medicine in 1910.  He served as a Captain in the U.S. Army Medical Corps during World War I.  He established a surgical practice in Cleveland, Ohio and was an Associate Professor of Surgery at Western Reserve University.  During that time period he worked with Dr. David Marine on the legendary trials of goiter prevention in the Akron, Ohio public Schools. From 1928 to 1943 he was the Chief of Pathology at the Cleveland Clinic.  During those years he co-authored many papers on thyroid disease with Dr. George Crile.  In 1944, he moved to Pittsburgh, PA. and became the Chief of Pathology at Western Pennsylvania Hospital until his retirement in 1952.

J.R. Yung

President, 1936

Julius Rudolph Yung Julius Rudolph Yung  Dr. Yung was born in Terre Haute, Indiana and graduated from the University of Illinois College of Medicine in 1900.  He completed a surgical residency at the New York Postgraduate Medical School and Hospital, and was a Captain in the Army Medical Corps in World War I.  He had additional training at several surgical clinics in Europe, including the de Quervain clinic in Berne, Switzerland.  He practiced surgery for over 50 years at the Rose Dispensary in Terre Haute, Indiana, specializing in thyroid surgery.

Nelson M. Percy

President, 1937

Nelson Mortimer Percy Nelson Mortimer Percy  Dr. Percy was born in Iowa and graduated from Rush Medical College in 1899.  He did n residency at Augustana Hospital in Chicago under Dr. Albert Ochsner, and was the surgical director of a U.S. Army base hospital in France during World War I.  He became the Chief of Surgery at Augustana Hospital in 1925 and wrote two surgical textbooks with Ochsner.  He was renowned for his expertise in thyroid surgery, and also for perfecting the Percy method of whole blood transfusion, consisting of running a tube directly from the donor’s vein to the recipient, and used by Chicago hospitals before World War II.

Frank H. Lahey

President, 1938

Frank Howard LaheyFrank Howard Lahey  Dr. Lahey grew up in Haverhill, Massachusetts and graduated from Harvard Medical School in 1904 and served as a surgical resident at Long Island Hospital in New York.  He was a staff surgeon at Boston City Hospital and on the surgical faculty of Harvard and Tufts medical schools.  After serving in the Army Medical Corps in World War I, he opened a practice in Boston that became the Lahey Clinic.  He pioneered “two-stage surgery”, in which surgery was completed in two steps over a period of two to four days.  This greatly improved surgical outcomes with a decrease in the mortality rate following thyroid surgery from 1-in-5 to 1-in-140.

He was appointed by President Roosevelt to serve on a special commission to report on medical standards during World War II.  He was President of the American Medical Association, the American College of Surgeons, and the International Society of Surgeons.  After his death in 1953, the Boston Globe stated that Dr. Lahey was “usually referred to as the outstanding general surgeon in the world today; at times of crisis he was never known to lose either his head or his nerve.” An article about his life published in the New England Journal of Medicine in 1953 stated: “His skill [brought] hundreds of surgeons from all parts of the world to see him operate and to share with him the knowledge and experience he was always ready to pass on to others.”

F.B. Dorsey, Jr.

President, 1939

Frank Blinn Dorsey, Jr. Frank Blinn Dorsey, Jr.  Dr. Dorsey was born in Missouri.  He entered Harvard Medical School in 1910, and graduated from the University of Iowa Medical School in 1912.  He practiced surgery with his father for many years in Keokuk, Iowa, and had a particular interest in goiter surgery.  He was a founder of Graham Hospital in Keokuk, Iowa, and taught surgery at the Keokuk College of Medicine, founded by his father, Frank Blinn Dorsey, Sr., which later became the State University of Iowa College of Medicine.

J.K. McGregor

President, 1940

ames Kenneth McGregorJames Kenneth McGregor  Dr. McGregor was born and raised in Watertown, Ontario and graduated from the University of Toronto School of Medicine in 1905. His surgical training included residencies in London and at the Mayo Clinic.  He founded the McGregor Clinic in Hamilton, Ontario and was the Chief of Surgery at Hamilton General Hospital.  He devoted career to solving problems related to thyroid surgery.

Dr. McGregor was a founder of the Hamilton Academy of Medicine, a Fellow of the Toronto Academy of Medicine, a Fellow of the Royal College of Surgeons of Canada, and of the American College of Surgeons.

Frank E. Rogers

President, 1941

 

J. deJ. Pemberton

President, 1942 – 1946

John de Jarnette PembertonJohn de Jarnette Pemberton  Dr. Pemberton grew up in North Carolina, and graduated from the University of North Carolina in 1907.  He graduated from the Pennsylvania School of Medicine in 1911, did a surgical residency at the Mayo Clinic starting in 1913, and received additional surgical training at the University of Minnesota, from which he received a Masters Degree in Surgery in 1918.  He was Chief of the Surgical Section at the Mayo Clinic from 1918, where he was a pioneer in thyroid surgery, until his retirement in 1952.

W.B. Mosser

President, 1947

William Blair MosserWilliam Blair Mosser  Dr. Mosser graduated from the University of Pennsylvania School of Medicine in 1922.  He did a surgical residency at University of Pennsylvania Hospital.  He became a faculty member there, where he specialized in thyroid surgery and was the surgeon to the goiter clinic at University Hospital. In 1928, he moved to Kane, PA where he became the Surgeon-in-Chief at Kane Community Hospital.

J. Howard Means

President, 1948

James Howard MeansJames Howard Means  Dr. Means graduated from Harvard Medical School in 1911.   He established the first thyroid clinic in Boston in 1920 at the Massachusetts General Hospital and helped introduce radioactive iodine as a tool in the diagnosis and treatment of thyroid disorders in 1941.   He was Jackson Professor of Clinical Medicine at Harvard from 1932 to 1951, acting dean of the Faculty of Medicine in 1946, and chief of medical services at Massachusetts General Hospital from 1924 to 1951.

Arnold S. Jackson

President, 1949

Arnold Stevans Jackson Arnold Stevans Jackson  Dr. Jackson graduated from the University of Wisconsin in 1916 and was a graduate of Columbia University Medical School.  He then did residency training at the Mayo Clinic.  He was the Director of the Jackson Clinic in Madison, Wisconsin and expert on thyroid disease.  He was the author of “Goiter and Other Diseases of the Thyroid”.  Was a world traveler and wrote many articles on his experiences.  Was a member of the American Medical Writers Association and was the President of the U.S. Chapter of the International College of Surgeons.

Samuel F. Haines

President, 1950

Samuel F. HainesSamuel F. Haines  Dr. Haines grew up in Rochester, MN and the family became good friends with the Mayo family; Dr. W.W. Mayo, became Samuel’s godfather.  A visit to the family’s home by Dr. Charles Mayo to care for a feverish 3-year-old Samuel inspired him to become a doctor.  He graduated from Harvard Medical School in 1919, and did a residency at the Massachusetts General Hospital.  He returned to work at the Mayo Clinic in 1924, where he and Dr. Henry Plummer worked together treating patients with thyroid disease and other endocrine disorders. He was Chairman of the Mayo Board of Governors for 8 years before retiring in 1957.

T.C. Davison

President, 1951

Thomas Callahan Davison Thomas Callahan Davison Dr. Davison was born in Woodville in Greene County, Georgia.    He graduated from the Atlanta College of Physicians and Surgeons in 1906 after he had worked as a pharmacist’s assistant in Richmond, Virginia.  He served in the first World War as a surgeon for Army Evacuation Hospital Number Four in France and later for a hospital in occupied Germany.  He interned and later was on the staff at Georgia Baptist Hospital where he helped form the Atlanta Cancer Clinic. He was an Assistant Professor of Clinical Surgery at Emory University School of Medicine in Atlanta, and Chief of Surgery at Grady Memorial Hospital in Atlanta.  He received numerous professional honors including an honorary membership in the International College of Surgeons.  He published five articles on thyroid disease and its treatment.

Willard O. Thompson

President, 1952

Willard O. Thompson Willard O. Thompson Dr. Thompson was born in New Brunswick, Canada.  He received a BA from Dalhousie University in Halifax, Nova Scotia and his MD from Harvard Medical school.  He was a fellow of the National Research Council and held research fellowships at Harvard Medical School and the Massachusetts General Hospital under Dr J.H. Means.

In 1929 he left Boston for Rush Medical College as Assistant and then Associate Professor of Medicine.  From 1941 until his untimely death in 1954 he was Clinical Professor of Medicine at the University of Illinois College of Medicine.  From 1930 to 1946 he was also attending physician at the Presbyterian Hospital, Chicago and, after 1946, Attending Physician at Grant, Henrotin and Illinois Research Hospitals.

His scientific contributions dealt primarily with thyroid disease. Between 1926 and 1937 his main focus was on the role of iodine in the control of Graves’ disease.  Later he studied the effects of diverse thyroid analogs on heat production and the course of myxedema.  In 1936 and 1938 he provided an early description of the stimulation of the human thyroid by thyrotropin.

Claude J. Hunt

President, 1953

Claude J. HuntClaude J. Hunt  Dr. Claude Hunt was born in Warren County, Kentucky.  He graduated from Bethel College, Russellville KY in 1910 and received his medical degree from the University of Kansas in 1915. He interned at Kansas City General Hospital until 1916 and then served in WW1 as a captain in the Medical Corps.  Dr Hunt did postgraduate work at Washington University in 1918, the University of Montpelier in France in 1919, Harvard University in1921 and the University of Vienna in 1929.  He was a former chief of surgical service at Kansas City General Hospital and an associate in surgery at the University of Kansas Medical Center.  He was also on the staff of the Menorah Medical Center and St Mary’s Hospital.  He retired in 1963.

He authored or co-authored many papers dealing with general surgery, six of them dealt with aspects of thyroid surgery.  He was founder and past president of the Missouri State Surgical Society and the Missouri division of the American Cancer. He was a member of several national and international societies including the International Surgical Society, the American board of Surgery and the New York Academy of Sciences.

Merrill N. Foote

President, 1954

Merrill N. Foote Merrill N. Foote  Dr. Merrill Foote was born in 1889 in New York and obtained his MD from Columbia University College of Physician and Surgeons.  He worked for many years in Brooklyn and Long Island and was a former regent of the American College of Surgeons.  During World War I, he served as captain with the US Medical Corps. He received the Distinguished Service award from the American Thyroid Association in 1957.  He published papers on several topics including thyroid surgery, thyroid cancer and treatment of hyperthyroidism with thiouracil.  At the time of his death, he was Director Emeritus of the Department of Surgery, St. John’s Episcopal Hospital in Brooklyn.

Richard B. Cattell

President, 1955

Richard B. CattellRichard B. Cattell Dr. Cattell was born in Martins Ferry, Ohio, obtained an AB degree from Mount Union College in Ohio, and his MD from Harvard Medical school. His graduate training was at St Luke’s Hospital in New York and at the Lahey Clinic. He joined the clinic’s staff in 1927 and became its director on the death of Dr. Frank Lahey, the founder, in 1953. He retired as director in 1962 because of illness.

Dr. Cattell was a specialist in surgery of the thyroid, pancreas and gastrointestinal tract and was a pioneer in reconstructive surgery of the biliary ducts.  His medical reputation attracted patients from all over the world to the Lahey Clinic.  Perhaps the most famous was Sir Anthony Eden, who was operated on by Dr. Cattell in 1953 and 1957.

He was a governor and a regent of the American College of Surgeons, a former president of the Interstate Postgraduate Medical Association and a director of the Massachusetts division of the American Cancer Society.

Among his awards were an honorary Doctor of Science degree from Boston University, the Boswell Park Medal of the Buffalo Surgical Society and the George B. Kunkel Surgical Medal of the Harrisburg (Pa.) Surgical Society.

Rulon W. Rawson

President, 1956

Rulon W. RawsonRulon W. Rawson After obtaining his MD, Dr. Rawson was a research fellow at Harvard Medical School and a staff physician at Massachusetts General Hospital. He later became a professor of medicine at Cornell University Medical College and chairman of the Department of Medicine at Memorial Sloan-Kettering Institute. He was also the dean at New Jersey College of Medicine and Dentistry, a professor of medicine and vice president for Education and Program Development at the University of Texas M.D. Anderson Hospital and Tumor Institute. Finally, Dr. Rawson became the director of the Bonneville Center for Research in Cancer Cause and Prevention in Salt Lake City. In addition to the ATA, he was also a member of numerous national committees and societies, including the Atomic Energy Commission, the American Cancer Society and the the Advisory Council on Health Manpower.

Dr. Rawson was very active in research throughout his career.  He is author or co-author on 113 research articles that include both clinical and basic science studies.  He investigated the actions of antithyroid medications, such as thiouracil in hyperthyroid patients in preparation for surgery and the utility of radioactive iodine scanning of the thyroid to assess function. He contributed greatly to the field of thyroid cancer, reporting the use of radioactive iodine for the diagnosis and eventual treatment of thyroid cancer and associated metastatic disease.

Brown M. Dobyns

President, 1957

Brown M. DobynsBrown M. Dobyns  Dr. Brown Dobyns was born in Jacksonville, IL in 1913.   He received his BA from Illinois College, his MD from Johns Hopkins University and his PH.D from University of Minnesota. He did his fellowships in surgery (GI, Thyroid) at the Mayo Clinic and the Massachusetts General Hospital. He was a surgeon, a scientific researcher, a humanitarian and a much-respected teacher. He worked at MetroHealth Medical Center (formerly Cleveland Metropolitan General Hospital) where he served as assistant chief of surgical services from 1951 to 1967 and associate director of surgery beginning in 1967. He retired in 1988 and became Professor Emeritus of Surgery at Case Western Reserve University School of Medicine.

He carried out research on radioiodine and developed the first stationary directional Geiger counter, which allowed him to locate tracer radioisotopes within the thyroid. He made thirteen trips to study and treat Marshall Islanders who were exposed to fallout from the first hydrogen bomb test off Bikini Atoll in the Pacific Ocean in 1953. He received a Fulbright Scholarship to teach for three months in Australia, after which he spent a month in the remote highlands of New Guinea studying goiters in native people whose diets lacked iodine.  In his day he was one of the world’s pre-eminent thyroid and parathyroid surgeons.

Elmer C. Bartels

President, 1958

Elmer C. BartelsElmer C. Bartels  Dr. Bartels was born in Hamilton, Ohio, circa 1902.  He graduated from the University of Illinois in 1923 and obtained his MD from its Medical School in 1927.  He served his internship at Western Penn Hospital and his residency in the Mayo clinic.   From 1935 to 1968 he served in the Lahey Clinic as a thyroid specialist and then went into private practice.  He was a past president of New England Baptist Hospital and Lahey Clinic staff.   He published at least 82 articles, many dealing with the chemical control of thyroid disease, with a focus on antithyroid drugs.  Dr. Bartels was 81 when he died.

Warren H. Cole

President, 1959

Warren H. ColeWarren H. Cole  Dr. Warren Henry Cole was born in Clay Center, Kansas, in 1898.  He obtained a BSc from the University of Kansas and an MD from the Washington University School of Medicine, St Louis, MI.  He interned at the City Hospital in Baltimore and then spent five years as a resident at Barnes Hospital, St Louis. He then returned to Washington University School of Medicine as instructor and then Associate Professor of Surgery. In 1936 he was appointed Professor of Surgery at the University of Illinois College of Medicine, where he remained for thirty years until his retirement in 1966. He was recognized internationally as a very able surgeon who advanced the frontiers of surgery. He had a particular interest in hepato-biliary surgery and the treatment of tumors of the thyroid gland.  In addition to being the co-author of three surgical textbooks, he contributed over three hundred articles to surgical journals.

He became a member of numerous associations and societies and president of most of them including the American Surgical Association, Western Surgical Association, Central Surgical Association, Southern Surgical Association, the Halsted Surgical Club, the Chicago Medical Society and the Chicago Surgical Society. He was chair of the Illinois State Medical Society’s Committee on Cancer Control, and president of the American Cancer Society in 1959/50. After that he served the American Cancer Society as director at large.

Edwin G. Ramsdell

President, 1960

Edwin G. Ramsdell Edwin G. Ramsdell  Dr. Ramsdell was born in New York, the son and grandson of physicians.  He graduated from Columbia University in 1905 and received an MD from its College of Physicians and Surgeons in 1908.  He was a practicing physician and surgeon in Westchester county for most of the subsequent 50 years.  In WW1 he was a major in the Army Medical Corp of the American Expeditionary Force and he saw action in the St Miheil and Argonne offenses.  For his war services he was made a Chevalier of the Legion of Honor and received the Croix de Guerre with Palm.

Dr. Ramsdell was a fellow of the American College of Surgeons, a fellow in Surgery of the New York Academy of Medicine, a member of the Founder Group of the American Board of Surgery and a member of the International Surgical Society.  He also receiver the first Columbia Lion Award  given in Westchester for distinguished public service.

Howard Mahorner

President, 1960

Howard R. MahornerHoward R. Mahorner  Dr. Mahorner was born in Mobile, Alabama in 1903.  He obtained a BA from Spring Hill College in Mobile, and a M.D. in 1925 from the University of Pennsylvania.  After an internship at Mercy Hospital in Pittsburg he entered the Mayo Foundation as a fellow in Medicine in 1926 and transferred to surgery in 1928.  He received an M.S. in surgery from the University of Minnesota in 1929.  He left the Mayo Foundation in 1930. He practiced surgery in Aberdeen, SD and then moved to New Orleans, where he became an instructor of surgery at Tulane University School of Medicine and eventually a Clinical Professor of Surgery at Louisiana State University School of Medicine, and Director of the Mahorner Clinic in New Orleans.

Dr. Mahorner was a founding member of the American Board of surgery.  In 1957 he served as president of the Southeastern Surgical Congress and in 1969 received its highest award.  He was also a past president of the New Orleans Chapter of the American Cancer Society and the alumni Association of the Mayo Clinic.  He was a fellow of the American College of surgeons, a member of the American Medical Association and a past President of the Southern Medical Association.

Dr. Mahorner co-authored two texts on subjects related to vascular surgery and published 68 articles in scientific Journals dealing with surgery of the vascular system, the biliary tract, and the thyroid gland.

Alexander Albert

President, 1961

Alexander Albert, MDAlexander Albert Dr. Alexander Albert was born in Spring Valley, NY in 1911.  He received a bachelor’s degree from Columbia University, and an M.A., PH.D and M.D. from Harvard.  After his internship and residency at the Beth Israel Hospital, he became a research fellow at the Massachusetts General hospital and later a staff physician in its thyroid clinic.  In 1946 he joined the Mayo Clinic as a research associate in thyroid physiology and became head of the Endocrine laboratory in 1947.  He was appointed a full Professor in 1955 and Chairman of the Department of Endocrine research in 1967.  In 1972 he was named senior consultant in the Department of Molecular Medicine.

Dr. Albert was nationally known for his endocrine research, which led to many publications; he was among the first to use radioactive iodine to study thyroid function in man and experimental animals. In 1955 he received the Award of Merit from the American Goiter Association.  He was a member of at least nine national scientific societies including the American Society for Clinical Investigation, the American Physiological Society, the Central Society for Clinical Research, the Society for Experimental Biology and Medicine and the Endocrine Society.  He served as a past president of the Endocrine society.

Virginia Kneeland Frantz

President, 1962

Virginia Kneeland Frantz Virginia Kneeland Frantz  Dr. Kneeland Franz the ATA’s first woman president.  She was born in New York City in 1896.  She graduated first in her class at Bryn Mawr College, and then, because of the Dr.op in male applicants to the all-male College of Physicians and Surgeons of Columbia University during WW1, she became one of the five women admitted and she obtained her M.D. in 1922, ranking second in her class.   She then became the first woman ever appointed to a surgical internship at the affiliated Presbyterian Hospital.  From 1924-27 she served as assistant surgeon to the outpatient department.  After that she joined the surgical pathology laboratory at Presbyterian.  During the following years Dr. Franz contributed a series of important pathological studies related to tumors of the thyroid, pancreas and breast.  She collaborated with renowned surgeon Allen Whipple in describing insulin-secreting tumors of the pancreas and she was among the first researchers to demonstrate the effectiveness of radioactive iodine for identifying and treating metastatic thyroid carcinoma.   She was also highly committed to teaching; from 1924 until her retirement in1962 she taught surgery to medical students at the College of Physicians and Surgeons, becoming a full Professor in 1951.

Dr. Franz was well recognized by her peers for her contributions to medical science as well as her engaging personality. She was elected President of the New York Pathological Society in 1949 and 1950.  She also received the Elizabeth Blackwell Award from the New York Infirmary in 1957 for distinguished service to Medicine.  After her retirement she continued as a consultant in surgery at the College of Physicians and Surgeons until her death in 1967.

John C. McClintock

President, 1963

John C. McClintock  John C. McClintock  Dr. McClintock was born in Iowa City, Iowa in 1906.  He received a B.S. from the University of Iowa in 1927 and an M.D. from its School of Medicine in 1929.  After an internship at the Montreal General Hospital, he completed a two-year fellowship in surgery at the Cleveland Clinic Foundation. He then served as a Clinical Assistant in Surgery at Northwestern University for two years.  In 1934 he moved to Albany Medical College, as an Instructor in Surgery, where he first became interested in thyroid surgery.   During WW11 he was assigned to the Third Auxillary Surgical Group, first as Captain and then Major.  He was on active service in the Mediterranean and Europe for over three years, receiving several military awards.  After the war he returned to Albany, devoting himself to thyroid surgery.  He was an Assistant Attending Surgeon (1937-1956) and then Associate Clinical Professor of Surgery (1956-1969) at Albany Medical College.   He was also Attending Surgeon (1956-1969) and Chairman of the Medical Staff at Albany Medical Center Hospital (1965).

Dr. McClintock was known internationally as an authority on the surgical management of the thyroid gland.  He belonged to the American Medical association, and the American College of Surgeons.  He was also a member of the Physicians Advisory Committee on Television, Radio and Motion Pictures of the AMA.  He served as secretary for the ATA from 1949-1961 and received its Distinguished Service Award in 1965.  He was the author of 45 scientific articles dealing with thyroid disease.

J.E. Rall

President, 1964

Joseph Edward Rall Joseph Edward Rall  Dr. “Ed” Rall, founder of the thyroid group at the NIH, was born in Naperville, IL in 1920, graduated from North Central College in Naperville, and received his medical training at Northwestern University Medical School and Wesley Memorial Hospital in Chicago.   His fellowship and residency at Mayo Clinic in Rochester, MN, began in 1945, was interrupted by 2-year military service in Germany at the end of World War II, and was completed in 1950. It was at Mayo that he began his career in thyroidology.  In 1952 he received a Ph.D. from the University of Minnesota for his work on the metabolism of labeled thyroid hormone.  In 1950 he joined Rulon Rawson at the Memorial Sloan Kettering Cancer Center in New York City, where he remained for the next 5 years. The group was engaged in the early development of treatment for metastatic thyroid cancer with radioactive iodine (I-131).  In 1955 he moved to the NIH to establish and lead the Clinical Endocrinology Branch at NIDDK.  In 1960 he was appointed Institute Scientific Director, a position he held for over 20 years, and in 1983 he became Deputy Director of Intramural Research for NIH. In 1991 he returned to the laboratory and in 1995 retired to Scientist Emeritus, still continuing research with a small group of international fellows.

Dr. Rall received the Distinguished Service Awards of both the ATA and The Endocrine Society. Among his many other honors, he was elected to membership in the Association of American Physicians, the National Academy of Sciences, USA, the Societe de Biologie, France, and the Royal Academy of Medicine, Belgium, and received honorary degrees from the University of Naples, Italy, and Charles University, Prague, attesting to his international prominence.

F.R. Keating, Jr.

President, 1965

F.R. Keating, JrF.R. Keating, Jr  Dr. Raymond Keating was born in Philadelphia in 1911 and received both his undergraduate and medical training at Cornell University, receiving his M.D. degree in 1936.  After his internship at Philadelphia General Hospital, he enrolled as a fellow in Medicine in the Mayo Graduate School of Medicine.  His work was of such high quality that in 1942 he was offered a position on the staff of the Mayo clinic in the endocrinology section. But first it was arranged for him to spend time at the MGH and MIT in Boston, chiefly with Dr.s. Howard Means, Fuller Albright, Saul Herz and Rulon Rawson, who were exploring the use of radioiodine in medical research and therapy. On his return to the Mayo Clinic, he started his own studies with radioiodine and published more than eighty scientific papers, many dealing with the use of radioactive iodine in the study of thyroid physiology and disease, and its use to treat the latter.  He was appointed Professor of Medicine in the Mayo Graduate School of the University of Minnesota In1953.  In 1965 he was appointed by the Surgeon General of the Public Health Service to a three-member panel to investigate the biological effects of residual atmospheric radiation produced by nuclear explosions.

Sadly, Dr. Keating was killed in a car accident in 1969, aged 58.

Lawrence W. Sloan

President, 1966

Lawrence W. SloanLawrence W. Sloan  Dr. Lawrence Sloan was born in 1897 in Salt Lake City and received his M.D. from Harvard Medical School in 1925.   He was a specialist in diseases of the thyroid gland and in 1947 joined the Columbia-Presbyterian Medical Center first as an associate professor and later full Professor of clinical surgery. During this period he was an attending surgeon at Presbyterian hospital.  He retired from both teaching and surgery in 1961, but continued as a consultant surgeon until 1972.  His six publications reflect his interest in thyroid nodules and cancer and also in the eye changes associated with disorders of the thyroid.

G. H. Klinck

President, 1967

Gustavus. H. KlinckGustavus. H. Klinck  Dr. Gustavus Klinck was born in 1903 and received his M.D. from the Medical College of South Carolina.  His specialty was pathology and he has twelve publications dealing primarily with the structural changes that occur in the thyroid in different diseased states.

Lindon Seed

President, 1968

Lindon SeedLindon Seed  Dr. Lindon Seed was born in 1897.  He received his MD degree in 1930 from Rush Medical College in Chicago and practiced medicine in Oak Park Illinois. His primary and secondary specialties were General medicine and General Surgery, respectively.  He was a member of the Chicago Medical Society, the National Society of Nuclear Medicine and the Central Surgical Society.

He has seven publications dealing with the use of radioiodine in the diagnosis and treatment of thyroid disease

John B. Stanbury

President, 1969

John B. StanburyJohn B. Stanbury  Dr. John Stanbury was born in Clinton, NC.  Received his undergraduate degree from Duke University and his M.D. from Harvard.  He served in the Navy during World War II, and raised a family of five in Chestnut Hill, MA.  He became chief resident at the Massachusetts General Hospital (MGH), and began his career in medical practice, teaching, and endocrine research when he became Chief of the Thyroid Unit at the MGH in 1949. The idea of studying endemic goiter using radioactive iodine led Dr.. Stanbury to organize a famous expedition to Mendoza, Argentina.  The research was published in 1954 in a landmark publication “Endemic Goiter: The Adaptation of Man to Iodine Deficiency”.  He ultimately pursued the “Iodine Trail” around the world with studies in Mexico, Ecuador, Venezuela, Brazil, Thailand, the Congo, and Indonesia.   These studies defined the extent of iodine deficiency–associated mental retardation and led to treatment programs using iodized salt and injections of iodinated oil, and the formation of the International Council for Control of Iodine Deficiency Disorders with Dr. Stanbury as its founding chairman.  In 1966, he moved to MIT as head of a clinical research center.

Dr. Stanbury received numerous awards and honorary degrees from countries around the world. In 2003, he established the Thyroid Pathophysiology Medal, which recognizes outstanding research contributions contributing to a greater understanding of thyroid physiology or the pathophysiology of thyroid disease and is awarded each year at the Annual Meeting of the ATA.

Dr.. Stanbury died just 8 weeks after his 100 birthday.

Theodore Winship

President, 1970

Theodore O .WinshipTheodore O .Winship Dr. Theodore Winship was born in Colorado in 1905.  He received an A.B. from the University of Nebraska in 1932 and an M.D. from its medical school in 1937.  He served in the US army in WW2 and was captured by the Japanese forces in the Battle pf Bataan and held prisoner for three years in the Philippines.  Following his released he practiced medicine in Washington, D.C., where he was a pathologist at the Washington Hospital Center, ultimately becoming Chief of Pathology.   He was a member of the American Medical Association, a diplomat of the American Board of Pathology and a fellow of the American College of Pathologists. He authored or co-authored thirty papers, many dealing with thyroid cancer, especially in children. He also published the results of studies in cultured thyroid cells.  He retired to Atlanta Georgia in 1973 and died the following year.  He was 68.

Samuel B. Barker

President, 1971

Dr. Samuel BarkerSamuel B. Barker  Dr. Samuel Barker was born in Montclair, NJ in 1912.  He obtained a B.S. from the University of Vermont in 1932 and a PhD in Physiology from Cornell University in 1936. After five years at the Cornell University Medical Center, he moved to the University of Tennessee medical school, and then in 1944 he joined the faculty in the physiology department at the University of Iowa. In 1952 was appointed Professor of Pharmacology at the Medical College of Alabama. He remained in Birmingham until 1962 when he accepted a position in the pharmacology department at the University of Vermont. Dr. Barker returned to Birmingham in 1965 as director of Graduate Studies at UAB, and in 1970 he was appointed first dean of the UAB Graduate School, remaining as dean until his retirement in 1978.  Dr. Barker also served as associate dean of the medical school and as associate dean of the dental school.  In 1976 he was selected as the Medical Center’s fifth Distinguished Faculty Lecturer and that same year was named a Distinguished Professor at UAB.  In 1979 he received an Honorary Doctor of Science degree from UAB and in 1991 he received the UAB President’s Medal.

Dr. Barker published nineteen papers.  His research interests included the peripheral actions of the thyroid hormones, with a focus on their effects on metabolic and cardiac effects.

Robert L. Kroc

President, 1972

Robert L. Kroc Robert L. Kroc   Dr. Robert Kroc was born and raised in Chicago, He obtained B.A. and M.A. degrees from Oberlin College and a PhD in Zoology from the University of Wisconsin.  From 1933-1944, Dr. Kroc was Instructor and then Assistant Professor of Zoology at Indiana University. In 1944 he began a career in biomedical research, joining the Maltine Company of Brooklyn, NY, which relocated to Morris Plains, NJ, and through various mergers, metamorphosed finally into the Warner-Lambert Pharmaceutical Company. Dr. Kroc had a remarkable record of achievement as Director of Physiology at the Warner Lambert Research Institute until he retired in 1969. He directed research that led to the development of Proloid® and Euthroid® for treatment of hypothyroidism, Simplastin® for measuring blood clotting time and Releasin® brand of relaxin for treatment of premature labor and threatened abortion. He co-authored eighteen scientific publications.

In 1969, Dr. Kroc moved to Santa Ynez, California where he became President of the Kroc Foundation, a philanthropic foundation initiated by his brother, McDonald’s Corporation founder, Ray Kroc. The Kroc Foundation dedicated itself to furthering scientific research in the fields of diabetes, multiple sclerosis, and arthritis through sponsorship of conferences at the Foundation headquarters at the J & R Ranch.

Dr. Kroc was a member of several scientific organizations, including the Endocrine Society and the American Physiological Society and a Fellow of the New York Academy of Sciences.

Sidney C. Werner

President, 1973

Sidney C. WernerSidney C. Werner Dr. Sidney Werner was born in 1909.  Columbia University was his academic home.  It was where he received his bachelor’s degree in 1929, his Master’s degree on 1932, his M.D. in 1937 and then fulfilled his internship and residency.  He served as Clinical professor of Medicine and chief of the thyroid clinic from 1962 to 1977. In 1977 he retired to Arizona, where he worked as a visiting Professor of Medicine at the University of Arizona Medical Center. A founder and president of the ATA, Dr. Werner also founded the New York Thyroid Club. He authored or co-authored more than 55 papers and in 1955, the first edition of his highly acclaimed textbook “Thyroid: a Fundamental and Clinical Text” was published.

Dr. Werner received many honors including the Jacobaeus Lecturer in Helsinki, the ATA’s Distinguished Service award and the Gold Medal for outstanding academic achievement from the Alumni Association of Columbia College of Physicians and Surgeons. The Sidney C. Werner Lectureship was established in his honor at the College of Physicians and Surgeons in 1977.  He was also an active member of the Endocrine Society and the American Society of Clinical Investigation.

David H. Solomon

President, 1974

David H. Solomon David H. Solomon Dr. David Solomon was born in 1923 in Brookline, MA.  He graduated from Brown University in 1944 and entered Harvard Medical School that year.  He obtained his M.D. in two years, graduating magna cum laude in 1946.  He completed his internship and residency at the Peter Bent Brigham Hospital in Boston and fulfilled a two-year military commitment in the U.S. Public Health Service at the Gerontology Research Center in Baltimore, Md.   Dr. Solomon was recruited to the new UCLA School of Medicine in 1952. He became the first board-certified endocrinologist in Los Angeles and led the development of the Division of Endocrinology in the new Department of Medicine at UCLA.  In 1966, he was named Chief of Medicine at Harbor General Hospital. He returned to UCLA’s main campus in 1971 as executive chair of the Department of Medicine, holding that position until 1981, when he began a second career in Geriatrics and Gerontology.

Dr. Solomon published more than 90 papers, reporting both clinical and basic science studies of thyroid physiology and disease.

Jacob Robbins

President, 1975

Jacob Robbins Jacob Robbins  Dr. Jacob Robbins was born in Yonkers, NY in 1922.  He obtained his undergraduate degree from Cornell University in 1944 and then entered Cornell Medical College in NYC.  His studies were interrupted when he joined the US army, and he received his M.D. in 1947.  After an internship in medicine, in 1950 he joined the team of Dr. Rulon Rawson at Memorial Hospital and Sloan Kettering Cancer Center as a research fellow.  In 1954 he joined the newly created NIH Clinical Center in Bethesda, MD. From 1963 to 1991 he was Chief of the Clinical Endocrinology Branch.

Dr. Robbins authored or co-authored more than 260 papers, many dealing with aspects of thyroid hormone economy, including the roles of free and protein bound thyroid hormones in the circulation.

He was a past Editor-in-chief of Endocrinology.  He received an honorary M.D. from the University of Messini, Greece, honorary memberships in the European Thyroid Association and the Italian and Japanese Endocrine Societies.  He became Scientist Emeritus (NIDDK, NIH,PHS) in 1995, but continued directing the Foundation for the Advanced Education in the Sciences at NIH (2000-2005) as President.

William M. McConahey

President, 1976

William M. McConaheyWilliam M. McConahey  Dr. McConahey was born in Pittsburg, PA in 1916, received a BA degree in 1938 from Washington and Jefferson College, and an MD in 1942 from Harvard Medical School. From 1943-45 he served in the US army. He was a Battalion surgeon in WWII and landed on Utah beach on D-Day +2.  He spent the remainder of the war in this role across Europe and Germany and was the first medical officer inside the infamous Flossenburg concentration camp when it was liberated by the Allied army.

Dr. McConahey joined the Mayo clinic as a fellow in Medicine in 1948 and received an M.S. degree from the University of Minnesota.  He was appointed to the faculty of the Mayo Graduate School of Medicine in 1950. In 1967 he was named the first Chairman of the Division of Endocrinology and held that position until taking senior consultant status in 1974.  Dr. McConahey authored or co-authored more than 100 scientific papers dealing with thyroid diseases, notably Graves’ and Hashimoto’s diseases and carcinoma of the thyroid.

Sidney H. Ingbar

President, 1977

Sidney H. IngbarSidney H. Ingbar Dr. Sidney Harold Ingbar was born in Denver, Colorado. He completed his endocrine fellowship at Harvard Medical Services and Thorndike Laboratory at the Boston City Hospital. He spent much of his career at Harvard Medical School where he served as Castle Professor and Director of the Thorndike Laboratory and Chief of Endocrinology at the Beth Israel Hospital.

He has received numerous awards for his research in thyroid physiology and pathophysiology. His research on thyroid hormone synthesis, transport, metabolism and action, autoimmunity, and cell growth resulted in over 350 scientific publications.  He reported the first conclusive evidence of peripheral conversion of T4 to T3.   He was chairman and principle investigator of the NIH Evaluation of Research Needs in Endocrinology and Metabolism, often referred to as the Inbar Report and was co-editor of the classic textbook, The Thyroid.

He has mentored over 100 associates, many of whom who have become academic leaders around the world and he served on several editorial boards.  The American Thyroid Association has honored him with Member of Council (1971-1975), President (1976), Parke-Davis Award (1978), and the Distinguished Service Award (1980).

Farahe Maloof

President, 1978

Farahe Maloof, M.D. Farahe Maloof, M.D.  Dr. Maloof was born in Boston, MA.  He graduated from Harvard College in 1942 and from Tufts Medical School in 1945.  He did his medical residency at Massachusetts General Hospital, where he also received his endocrinology training. He was Professor of Medicine at Harvard Medical School and Chief of the Thyroid Unit at the Massachusetts General Hospital from 1966-1980.  Dr. Maloof was a pioneer in the use of radioiodine to treat metastatic thyroid cancer.  He was one of the first investigators to report hyperthyroidism caused by a TSH secreting pituitary tumor, and his research on thyroid peroxidase helped to elucidate the mechanism of action of antithyroid drugs.

 

Alvin B. Hayles

President, 1979

Alvin B. Hayles M.D. Alvin B. Hayles M.D.  Dr. Alvin B. Hayles was born in Atmore, Alabama and received his medical degree from Washington University, Missouri.  He served as a medical officer in the United States Navy prior to completing a residency in pediatrics at Mayo Graduate School of Medicine. He practiced pediatrics in Lincoln, Nebraska for two years before returning to Mayo Clinic. A self-taught pediatric endocrinologist, he developed the Division of Pediatric Endocrinology at the Mayo Clinic.

His expertise was in thyroid disease and cancer in children, as well as pituitary and parathyroid disorders.  His work resulted in 147 publications.  From 1971-1976, he was the Editor-in-Chief for Mayo Clinic Proceedings.  He was a founder and first chairman of the Subspecialty Board of Pediatric Endocrinology in 1976 and was reelected by his colleagues for six consecutive years. He helped establish and served as president of the Lawson Wilkins Pediatric Endocrine Society in 1978.  Dr. Hayles received the Distinguished Service Award of the American Thyroid Association and the Minnesota State Medical Association.

Monte A. Greer

President, 1980

Monte Greer M.D.Monte Greer M.D. Dr. Monte Greer, a native of Portland, Oregon, attended Oregon State College where by chance he took a course in endocrinology.  This was the beginning of a career in thyroid that would span over 50 years.  He completed Stanford Medical School and a fellowship with Dr. Edwin B. Astwood in Boston, Massachusetts, where he discovered yellow turnip blocked the uptake of radioactive iodine by human thyroid. The group eventually isolated the chemical structure of the turnip goitrogen, naming it goitrin.  Greer went on to be a senior investigator at the National Cancer Institute where his main interest was the physiology of the hypothalamic-pituitary-thyroid axis, which would be his focus for 40 years. He led the Oregon Health Science University Endocrinology Division for 33 years where he continued his work in the HPT axis along with his daughter, Susan, who collaborated with him for the last two decades of his laboratory work.  Dr. Greer pioneered the use of thyroid hormone to treat goiter and thyroid nodules, treating hyperthyroidism with once-a-day antithyroid therapy, and only treating until the patient was euthyroid.

Robert Volpe

President, 1981

Robert Volpe M.D. Robert Volpe M.D.  Dr. Robert Volpe was born in Toronto and served in the Royal Canadian Navy during the Second World War before enrolling in the University of Toronto Medical School.  After completing his residency and fellowship there, he joined the faculty. A Professor Emeritus from the University of Toronto, Dr. Volpe published over 300 journal articles, book chapters, reviews, and editorials including the book, Thyroid Function and Disease.  He was a founding member of the Canadian Society for Endocrinology and Metabolism and governor of the Ontario chapter of the American College of Physicians. He played a leading role in the development to the Thyroid Foundation of Canada.  He received honorary fellowships by the Royal College of Physicians of Edinburgh in 1992 and of London in 1995. For his significant contributions in Canada, he was appointed an Officer of the Order of Canada in 2003.

Leslie J. DeGroot

President, 1982

Leslie J. DeGroot M.D. Leslie J. DeGroot M.D.  Dr. Leslie J. DeGroot was born on a dairy farm in upstate New York.  He attended Columbia University for medical school and after residency, entered the Public Health Service where he worked with Dr. Monte Greer before beginning a research fellowship with Dr. John Stanbury at Massachusetts General Hospital.

He led the University of Chicago’s Thyroid Study Unit for thirty-six years.  Publishing 462 papers, he was a pioneer in the study of thyroid hormone resistance, iodine metabolism, prevention and treatment of thyroid cancer and autoimmune thyroid disease.  Along with his colleagues Dr. Samuel Refetoff and Frederick H. Rawson, he published a study in the New England Journal of Medicine in 1975 indicating the connection between thyroid cancer prevalence and the prior practice of x-ray treatment for benign childhood diseases.

He edited six editions of the textbook, “Endocrinology”, was president of Endocrine Education, publisher of endotext.org and thyroidmanager.org. which provided free access to people all around the world.  He is the recipient of numerous awards, including the Distinguished Research Award from the American Thyroid Association in 1993.

David V. Becker

President, 1983

David Becker M.D David Becker M.D  Dr. David Becker was born in New York City and graduated from Columbia University and the New York University School of Medicine.  After graduating he took a research fellowship at Memorial-Sloan-Kettering Cancer Center and began his work on radioiodine. A pioneer in the field of nuclear medicine, he served in the US Army and set up a radioisotope laboratory at Brooke Army medical Center during the Korean War.  In 1955 he founded the Division of Nuclear Medicine at New York-Presbyterian Hospital Weill Cornell Medical Center and served as its director for more than 40 years.

He was one of the first to use radioiodine for imaging the thyroid, diagnosing, and treating hyperthyroidism and thyroid cancer.  He established radioiodine as a clinical tool and also studied its adverse effects.  His research led to the development of national and international policies for treating people exposed to radiation from reactor accidents.  He led the National Cancer Institute’s team investigating the effects of the 1986 Chernobyl reactor accident and helped create health monitoring and treatment plans as a consultant to the NCI for over 30 years. In recognition of his work, he received a White House Citation for Humanitarian Efforts in 1996.

J. Maxwell McKenzie

President, 1984

John Maxwell McKenzie M.D.John Maxwell McKenzie M.D. Dr. McKenzie came to the United States from Scotland by way of Canada.  He graduated from St. Andrew University in Dundee in 1950, served as a medical officer in Korea, and returned to Dundee to complete his residency. He then moved to Boston to work with Dr. Edwin B. Astwood.  In Boston, he developed a mouse thyrotropin bioassay, the McKenzie bioassay for thyrotropin.  In 1959, he went to McGill University and became Chief of Endocrinology and Metabolism and remained in Montreal until 1981 after which he moved to the University of Miami where he served as the Chief of Endocrinology and Chair of Medicine.  He continued his work as a scientist while serving in his leadership roles.  When he retired in 2006, he was honored with a fellowship training program in his name.

Lewis E. Braverman

President, 1985

Lewis E. Braverman M.D. MACE, MCAPLewis E. Braverman M.D. MACE, MCAP  Dr. Lewis E. Braverman was born in Quincy, MA. He received his medical degree from Johns Hopkins University School of Medicine, completed his residency at Boston City Hospital, and a fellowship under Dr. Sidney H. Ingbar at the Thorndike Memorial Laboratory.  He was Chief of Endocrinology at St. Elizabeth’s Hospital in Boston, founding Director of Endocrinology and Chief of Nuclear Medicine at the University of Massachusetts Medical Center and Chief of Endocrinology, Diabetes, and Nutrition at Boston Medical Center, Boston University.

He was a prolific thyroid researcher and published more than 600 publications.  His seminal work included the demonstration that thyroxine was converted to triiodothyronine in humans in 1970.  In 1982 he identified a new genetic disorder, familial dysalbuminemic hyperthyroxinemia.  In 1987, he discovered the etiology of an outbreak of thyrotoxicosis in the Midwest was due to inclusion of cow thyroid gland in several meat processing plants.

He was an international expert in iodine metabolism and a longtime editor of the leading thyroid textbook, The Thyroid: A Fundamental and Clinical Text.  Dr. Braverman was the recipient of all the major awards of the American Thyroid Association, the Endocrine Society, and the American Association of Clinical Endocrinologists.  He served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism and Endocrine Practice. He was named Masters of the American College of Endocrinology and the American College of Physicians.

He mentored more than 70 fellows as well as hundreds of students, residents, and junior faculty.  In honor of his dedication to mentoring, the American Thyroid Association established the Lewis E. Braverman Lectureship in 2011.

Jack H. Oppenheimer

Jack H. Oppenheimer M.D

President, 1986

Jack H. Oppenheimer M.D  Dr. Jack Oppenheimer, born in Egelsbach, Germany attended Princeton University prior to medical school at Columbia University. He established the Endocrine Research Laboratory at Montefiore Hospital/Albert Einstein College of Medicine, known throughout the world for several important research findings on thyroid physiology, pathophysiology, and mechanisms of thyroid hormone action.

His contributions included demonstrating dilantin’s effect on thyroxine binding, the first practical method for measurement of free thyroid hormones, initial studies on euthyroid sick or low T3 syndrome, the extent of T4 conversion to T3 and the inhibitory effect of PTU on conversion, T3 as the principal active thyroid hormone, rapid exchange between thyroid hormone in the blood and tissues, and physiologic replacement dosing.  He published more than 270 papers and trained nearly 75 endocrine fellows and graduate students.

He was elected to the American Society of Clinical Investigation and the Association of American Physicians, served on several editorial boards and in the endocrine section for the National Institute of Health.  He was a recipient of the American Thyroid Associations’ Van Meter Award in 1965 and the Distinguished Service Award in 1992.

Gerard N. Burrow

President, 1987

Gerard N. Burrow M.D.Gerard N. Burrow M.D.  Dr. Gerard Burrow was born in Providence, Rhode Island.  He earned his medical degree from Yale and completed his endocrine fellowship at Grace-New Haven Hospital before spending two years with the United States Public Health Service in Japan where he studied the effects of prenatal exposure to radiation and developed an interest in radiation-induced thyroid cancer.

His academic work focused on thyroid disorders related to pregnancy.  He co-founded the high-risk pregnancy clinic at Yale and authored Medical Complications During Pregnancy and co-edited the Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and therapeutic Aspects.

He was very involved in task forces on health care reform and medical education.  He was a member of the National Cancer Institute advisory board on the health effects of 1986 Chernobyl disaster and chair of the Institute of Medicine’s Committee on the Department of Defense Persian Gulf Syndrome Comprehensive Clinical Evaluation Program. As chair of the International Council for the Control of Iodine Deficiency Disorders, he traveled the world advocating for the use of iodized salt.

John T. Nicoloff

President, 1988

John T. Nicoloff M.D. John T. Nicoloff M.D.  Dr. John T. Nicoloff received his A.B in zoology and his medical degree from the University of California Los Angeles. After residency, he completed a NIH-sponsored fellowship at the University of Washington. He spent the majority of his career at the University of Southern California where he served as Chief of Division of Endocrinology.

During his time at USC he created and directed the General Clinical Research Center for three decades and he served as the chair of the NIH Thyroid Task Force.  Per Dr. Carole Spencer, his colleague for over 40 years, he was most proud of developing the dual isotope thyroidal iodine release method (TIR), used to indirectly measure TSH prior to the advent of direct TSH measurement.

Dr. Spencer and Dr. Nicoloff spent two decades improving the sensitivity of the TSH assay to that of the current 3rd generation assay and then worked to sensitize the thyroglobulin (Tg) radio-immunoassay.  His other contributions included the demonstration that non-hepatic tissues were a main source of circulating T3 and the changes in T3 associated with illness.

The American Thyroid Association honored him with the Paul Starr Award (1984), The Distinguished Service Award (2004), and the Thyroid Pathophysiology Award (2008).

Delbert A. Fisher

President, 1989

Delbert A. Fisher M.D. Delbert A. Fisher M.D. Dr. Delbert A. Fisher was born in Placerville, California.  He earned his medical degree from the University of California, San Francisco before completing his fellowship in pediatric endocrinology at the University of Oregon.  He served as Chief of Pediatrics and Endocrinology at Harbor-UCLA Medical Center, director of the Walter Martin Research Center, President and Chief Officer of Nichols Institute, and Vice President of science and innovation for Quest Diagnostics.

Dr. Fisher pioneered the use of NA-1-thyroxine for replacement in congenital hypothyroidism.  He made the observation of neonatal thyroidal hyperactivity as a response to neonatal cooling and noted the high thyroxine secretion rate in infants as well as the changes in iodine metabolism and thyroxine production with age.  He was the first to describe limited placental transfer of thyroxine, the low T3, high reverse T3 state of the fetus, and its rapid reversal secondary to increased type 1 deiodinase activity in the newborn period.

At Harbor-UCLA, he focused on hormone immunoassay development.  Dr. Jean Dussault, his first fellow at UCLA, along with C. Laberge developed the first mass populations screening program for congenital hypothyroidism.  Dr. Fisher chaired the Newborn Screening Committee of the American Thyroid Association which oversaw the collaborative monitoring and development of these programs.  Due in large part to his work and contributions, newborn hypothyroid screening is now standard practice in the industrialized world and has virtually eliminated sporadic congenital hypothyroidism as a cause of mental retardation.

He was named to the Hall of Honor by the National Institute of Health in 2003 and honored with Marquis Who’s Who In America in 2016.

John F. Wilber

President, 1990

John Wilber M.D. John F. Wilber M.D.  Dr. John F. “Jack” Wilber was born in Bronxville, New York.  He graduated cum laude from Harvard Medical School in 1961, a member of Alpha Omega Alpha.  He completed a fellowship in endocrinology at Barnes Hospital and the Washington University School of Medicine.  As a clinical associate of the National Institute of Health, he developed the first successful TSH radio-immunoassay.

He became a full professor at the Washington University School of Medicine in 1973 before moving to Louisiana State University Medical Center and the University of Maryland School of Medicine, where he led the Division of Endocrinology.  He has published over one hundred papers. His research looked at thyrotropin-releasing hormone and its regulation.  He demonstrated that T4 and T3 led to TRH inhibition.

As president of the American Thyroid Association, he established the ATA editorial board. He served as a member of the editorial board of The Journal of Clinical Endocrinology and Metabolism, Thyroid University Case Reports, the American Journal of Medical Sciences, and was a reviewer of the Journal of Clinical Investigation. He traveled extensively giving lectures around the world with Doctors Without Borders.

Constance S. Pittman

President, 1991

Constance S. Pittman M.D.Constance S. Pittman M.D.   Dr. Constance Shen-Pittman was born in Nanking, China and trained as a nurse in China before coming to the United States to study at Wellesley College as a Mayling Soong Foundation scholar.  She earned her medical degree from Harvard Medical School and interned at the Johns Hopkins Service at Baltimore City Hospital before completing her residency and fellowship at the University of Alabama School of Medicine.  She served as Chief of the Endocrinology Service at the Birmingham VA Medical Center for nearly two decades and was a Professor Emeritus of Medicine at University of Alabama at Birmingham.

Dr. Pittman’s research related to thyroid physiology and pathophysiology, investigating the role of iodine in thyroid biochemistry and function.  Her work contributed significantly to our understanding of thyroid hormone biosynthesis and metabolism.  She was funded for more than 30 years and authored almost 70 papers on basic and clinical thyroidology and endocrinology.  In the last two decades of her life, Dr. Pittman worked with Kiwanis International and UNICEF toward eradicating iodine deficiency worldwide.  For her work, she received the Andrew Gerow Hodges Service Award from the Kiwanis Club of Birmingham in 2005.

Ralph R. Cavalieri

President, 1992

Ralph R. Cavalieri M.D.Ralph R. Cavalieri M.D.  Dr. Ralph Cavalieri was born in New York City.  He graduated summa cum laude from New York University before receiving his medical degree there.  He served as chief resident at Bellevue Hospital and then served in the U.S. Naval Hospital in Bethesda, Maryland before going to London as a NATO Fellow at the National Institute for Medical Research.  After completing his fellowship at Johns Hopkins, he served as Chief of Nuclear Medicine at the Fort Miley Veterans Affairs Medical Center of San Francisco for 35 years.

Professor Emeritus of Medicine and Radiology at the University of California, San Francisco, Dr. Cavalieri was a teacher, clinician, and researcher.  He contributed over 100 papers in thyroid, metabolic, and nuclear research.  His focus was on thyroid hormone metabolism.  He received numerous honors and awards and was elected to the American Society for Clinical Investigation and the American Association of Physicians.  Even after he retired, Dr. Cavalieri returned to study new biochemical and genetic techniques applicable to thyroid.

Jerome M. Hershman

President, 1993

Jerome M. Hershman, MD, MS, MACP Jerome M. Hershman, MD, MS, MACP  Jerome M. Hershman, MD, MS, MACP was Distinguished Professor Emeritus of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles, and Attending Consultant of the Endocrine Clinic at the West Los Angeles VA Medical Center in California.  After completing his fellowship at the Tufts New England Medical Center, he joined the faculty in the Department of Medicine at Northwestern University, Chicago, before moving to the University of Alabama, Birmingham, and then to UCLA in 1972.

Dr. Hershman was known for his research characterizing the thyrotrophic activity of hCG and, more recently, for his research in the management of thyroid cancer.  He published over 500 papers and reviews and served as the first Editor-in-Chief of Thyroid in 1991-1999, followed for another 8 years by his role as Editor-in-Chief of Clinical Thyroidology.

P. Reed Larsen

President, 1994

Reed Larsen, MD, FACP, FRCP  Reed Larsen, MD, FACP, FRCP  Philip Reed Larsen, MD has been a member of the Harvard Medical School faculty since 1974 when he became Chief of the Thyroid Division at Brigham and Women’s Hospital in Boston.  He was appointed Professor of Medicine in 1982 and served from 2002-2007 as Chief of the Division of Endocrinology, Diabetes and Hypertension.  For more than 20 years he has served as a Howard Hughes Investigator.

He is the recipient of multiple awards, including the Van Meter, Braverman Distinguished Lectureship, and Pathophysiology Awards from the American Thyroid Association and an elected member of the American Society for Clinical Investigation.  He has served on many editorial boards, including those for Williams Textbook of Endocrinology and Nature Clinical Practice Endocrinology and Metabolism.  Dr. Larsen is recognized for his research in screening newborn infants for congenital hypothyroidism and initiating two regional screening programs in Massachusetts.  He also is known for his research defining T4 regulation of TSH secretion and the biochemical characterization of the type 2 deiodinase.

Leonard Wartofsky

President, 1995

Leonard Wartofsky, MD, MPH, MACPLeonard Wartofsky, MD, MPH, MACP  Leonard “Len” Wartofsky, MD, MPH, MACP is Emeritus Chairman of the Department of Medicine at Washington Hospital Center and a Professor of Medicine at Georgetown University School of Medicine as well as at the Uniformed Services University of the Health Sciences, and George Washington, Howard, and Maryland University Schools of Medicine.  He holds MS, MD, and MPH degrees from George Washington University and trained in endocrinology at Harvard University/Boston City Hospital under Sidney Ingbar, MD.  At Walter Reed Army Medical Center, he was Director of Endocrinology and then Chair, Department of Medicine, and Consultant in Medicine to the Surgeon General.

Dr. Wartofsky has been elected to several honorific societies, including the American Society of Clinical Investigation, Association of American Physicians, Association of Professors of Medicine, and as Governor of the American College of Physicians.  He is past President of both the American Thyroid Association and The Endocrine Society.  Among his many awards, he has received the John B. Stanbury Pathophysiology Medal and the Lewis E. Braverman Distinguished Lectureship Award of the American Thyroid Association.

Dr. Wartofsky’s major clinical and research interest is in the management of patients with thyroid cancer, and he is the author of over 400 articles and book chapters in the medical literature.  He has served as the editor of several endocrine texts and was the Editor-in-Chief of both The Journal of Clinical Endocrinology and Metabolism and Endocrine Reviews.

Colum A. Gorman

President, 1996

Colum A. Gorman, MBBCh, PhD, MB, BChColum A. Gorman, MBBCh, PhD, MB, BCh   Colum Gorman, MBBCh, PhD, MB, BCh, a native of Northern Ireland, joined the Mayo Clinic School of Medicine and Science as a Fellow in Internal Medicine in 1965.  He served as Professor of Medicine, Chair of the Division of Endocrinology, Diabetes, Metabolism and Nutrition, and Associate Director for Research Development at the Mayo Clinic in Rochester, Minnesota.  Dr. Gorman retired in 2012 as Emeritus Professor of Medicine.

Throughout his career, Dr. Gorman focused his research and clinical efforts on optimizing the diagnosis and treatment of Graves’ ophthalmopathy.  He received multiple awards, including the Distinguished Service Award from the American Thyroid Association in 1990 and the Paul Starr Award in 2001.  He has been an active ATA member for over 40 years, serving on multiple committees, the Board of Directors, as Secretary, and as President in 1996.

E. Chester Ridgway

President, 1997

Chester Ridgway, MD Chester Ridgway, MD  Chester Ridgway, MD, “Chip” to his family, friends, and colleagues, followed his primary care physician father into the practice of medicine. He received his undergraduate degree at Dartmouth College and his MD degree from the University of Colorado Medical School.  Following his residency and fellowship at Harvard Medical School, he joined the faculty at Harvard University and the Massachusetts General Hospital where he was Head of the Thyroid Unit.  In 1985 he returned to the University of Colorado School of Medicine as the Head of the Division of Endocrinology, Metabolism and Diabetes, a position he held until 2007. In 1995 Dr. Ridgway was appointed Senior Associate Dean for Academic Affairs within the School of Medicine. In 2006 he was appointed Vice Chair for the Department of Medicine and Interim Chair for the Department of Medicine in 2010.

Dr. Ridgway’s research and clinical interests were in disorders of the thyroid and pituitary glands.  He served as the President of the American Thyroid Association in 1997 and President of the Endocrine Society in 2003.  He established and for 20 years directed the highly regarded Endocrine Fellows Conference, providing an important educational opportunity to trainees in thyroidology.  Dr Ridgway unfortunately passed away from pancreatic cancer in 2014.

Paul J. Davis

President, 1998

Paul J. Davis, MD, MACPPaul J. Davis, MD, MACP  Paul J. Davis, MD, MACP is Professor of Medicine at Albany Medical College in Albany, New York and Adjunct Professor of Pharmacy at Albany College of Pharmacy and Health Sciences.  He is also Executive Vice President and Chief Scientific Officer at NanoPharmaceuticals LLC in Rensselaer, New York.

Dr. Davis obtained his MD degree at Harvard Medical School and completed his endocrine training at the NIH.  He has served on the tenured medical faculties of Johns Hopkins University, the University at Buffalo, and Albany Medical College where he chaired the Department of Medicine for ten years.  He has been a member of 12 U.S. Department of Veterans Affairs research and clinical committees, has served on multiple NIH committees and, for six years, was a member of the Extramural Review Panel of the Chernobyl Tissue Bank of the European Union.

Dr. Davis has co-authored over 300 research publications, defining the molecular bases of thyroid hormone action, co-edited four scientific textbooks, and served on multiple editorial boards.  He served in elected offices of the American Board of Internal Medicine and the American College of Physicians.  He co-discovered the cell surface receptor for thyroid hormone analogues on integrin avb3 and co-founded NanoPharmaceuticals, LLC.

Orlo H. Clark

President, 1999

Orlo H. Clark, MDOrlo H. Clark, MD Orlo H. Clark, MD is Emeritus Professor of Surgery in the Department of Surgery at the University of California, San Francisco.  He completed a fellowship in endocrine surgery at the Hammersmith Hospital/Royal Postgraduate Medical Center in London and joined the UCSF faculty in 1973.

Before retiring, Dr. Clark was the Chief of Surgery and the Vice Chair of the Department of Surgery at Mt. Zion Medical Center, San Francisco.  He has served as the President of the American Association of Endocrine Surgeons, the International Association of Endocrine Surgeons, and the Pacific Coast Surgical Association as well as the American Thyroid Association in 1999.  He is an honorary member of the German Surgical Society and the Turkish and Asian Endocrine Societies.  The author and co-author of over 300 papers, chapters, and books, Dr. Clark has focused his research efforts on the genetic basis and growth factors of familial thyroid cancer.

Martin I. Surks

President, 2000

Martin I. Surks, MDMartin I. Surks, MD  Martin I. Surks is Professor of Medicine and Pathology at Albert Einstein College of Medicine and Program Director, Endocrinology and Metabolism, in the Department of Medicine at Montefiore Medical Center in New York.  A member of the American Board of Internal Medicine subspecialty committee on Endocrinology, Diabetes and Metabolism, he was a founding member of the American Association of Program Directors of Endocrinology and Metabolism and later served as its president.   Dr. Surks led a collaborative project resulting in a curriculum for endocrinology training programs widely used today and is the chair of the Endocrine Self-Assessment Program of the Endocrine Society.

Dr. Surks has served on the editorial boards of Thyroid, Endocrinology, the Journal of Clinical Endocrinology and Metabolism, and the American Journal of Physiology.  He is the recipient of multiple awards, including the Distinguished Service Award from the American Thyroid Association and a mastership from the American College of Physicians.

William W. Chin

President, 2001

William Waiman Chin, MD William Waiman Chin, MD  William W. Chin, MD is Emeritus Professor of Medicine and Bertarelli Professor of Translational Medical Science, Emeritus, at Harvard Medical School in Boston.  During his tenure as a faculty member in the Department of Medicine at Brigham and Women’s Hospital, he served as Chief of the Genetics Division, Executive Dean of Research, and as a Howard Hughes Medical Institute investigator, as well as Professor of Medicine and Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School.

In addition to his important roles in academia and the many awards he has received, Dr. Chin has worked as Senior Vice President for Discovery Research and Clinical Investigation at Eli Lilly and Company and, currently, is Executive Vice President, Clinical and Translational Science, and Chief Medical Officer at Frequency Therapeutics in Woburn, Massachusetts.

His research efforts have been focused on the structure, function, and regulation of hormone genes and produced over 300 papers, chapters, and textbooks.

Carole A. Spencer

President, 2002

Carole Ann Spencer, PhD, FACBCarole Ann Spencer, PhD, FACB  Carole Spencer, educated in England and Scotland, is Professor of Research Medicine in the Keck School of Medicine of the University of Southern California where she is a licensed Medical Technologist and the Technical Director of the USC Endocrine Services Laboratory.  The author of over a hundred original papers, chapters, and monographs, she has focused her research interests on thyroglobulin and thyroid cancers, parameters for optimizing thyroid hormone suppression of TSH for DTC, hypothalamic/pituitary mechanisms for regulating TSH, and testing for thyroid dysfunction during pregnancy.

Dr. Spencer is the recipient of many awards from the Clinical Ligand Society, the American Association of Clinical Chemistry, the National Academy of Clinical Biochemistry, and an award for publishing excellence from the Endocrine Society.

Peter A. Singer

President, 2003

Peter A. Singer, MDPeter A. Singer, MD Peter A. Singer, MD is Professor of Clinical Medicine at the Keck School of Medicine of the University of Southern California and Director of the USC Thyroid Diagnostic Center.  He has received multiple professional awards recognizing his efforts in clinical practice and medical education, including the 2013 Distinguished Service Award from the American Thyroid Association, the 2020 Vigersky Outstanding Clinical Practitioner Award from the Endocrine Society, the 2004 Outstanding Clinical Endocrinologist Award and the 2017 Award in the Humanities and Ethics from the American Association of Clinical Endocrinologists, and the 2018 Excellence in Science Award from the Vietnam Veterans of America.  For over 40 years, Dr. Singer has chaired an annual thyroidology symposium for primary care physicians.

Dr. Singer has devoted over 30 years of medical volunteer work in Vietnam, serving as Chairman of the East Meets West Foundation, an international organization providing medical care to underserved populations in southeast Asia.  In recent years, he has provided medical education to Vietnamese physicians and delivered the 2020 commencement address at Tan Tao University Medical School in Long An Province, Vietnam.

Clark T. Sawin

President, 2004

Clark T. Sawin, MDClark T. Sawin, MD  Clark Timothy Sawin, MD, a Boston native, completed a U.S. Public Health postdoctoral research fellowship in endocrinology at the New England Medical Center Hospitals and joined the faculty at Tufts University Medical School as Professor of Medicine in 1966 and at Boston University Medical School in 1994.  He served as chief of the endocrine-diabetes section at the Boston VA Medical Center from 1996 to 1998 and, until his death in 2004, served in Washington, DC as chief medical quality control officer for the VA health care system nationwide.  He also served on the editorial boards of Thyroid, the Journal of Clinical Endocrinology and Metabolism, and Endocrine Practice.

Dr. Sawin had a lifelong interest in the history of endocrinology and wrote over 80 historical vignettes.  He was a frequent speaker at national and international conferences on this topic and served as chair of the ATA history and archives group for many years.  After his death, to continue Dr. Sawin’s work in endocrinology history, his family has established the Clark T. Sawin History Resource Center at the ATA and the Clark T. Sawin Memorial Library and Resource Center at The Endocrine Society.

Paul W. Ladenson

President, 2005

Paul W. Ladenson, MDPaul W. Ladenson, MD  Paul W. Ladenson, MD is the John Eager Howard Professor of Endocrinology and Metabolism and Professor of Medicine, Pathology, Oncology, Radiology, and Radiological Sciences at Johns Hopkins University School of Medicine, where he is also University Distinguished Professor.     Dr. Ladenson was raised in Missouri and educated at Dartmouth College, Oxford University, and Harvard Medical School before training at Massachusetts General Hospital.  Dr. Ladenson’s principal research interests have focused on the diagnosis and management of thyroid cancer, thyroid hormone actions on the heart, and applications of thyroid hormone analogs.

In addition to his important leadership roles in the American Thyroid Association, Dr. Ladenson also has served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism and past Chair of the ABIM Specialty Board Examination Committee for Endocrinology, Diabetes, and Metabolism.  He is the author of over 250 publications.

Ernest Mazzaferri

President, 2006

Ernest L. Mazzaferri, Sr., MD, MACP Ernest L. Mazzaferri, Sr., MD, MACP  Ernest L. Mazzaferri, Sr., MD, MACP, “Ernie” to his family, friends, and colleagues, spent most of his career at the Ohio State University School of Medicine where he served as Director of the Division of Endocrinology, Diabetes, and Metabolism and Chair of Internal Medicine.  He subsequently “retired” from his leading role at OSU and became an active faculty member at the University of Florida in Gainesville.  In addition to his role as physician, educator, mentor, and researcher, known for his groundbreaking work in thyroid cancer management, he served as Lieutenant Colonel in the U.S. Air Force Medical Corps and the U.S. Army Reserves, a responsibility that included active-duty service during Desert Storm at Madigan Army Medical Center in Tacoma, Washington.

Dr. Mazzaferri was elected as a Master of the American College of Physicians, Chair of the Endocrinology and Diabetes Section of the American Board of Internal Medicine, and a member of the ABIM Board of Directors.  He served as the first chair of the National Comprehensive Cancer Network guidelines committee on thyroid nodules and cancer.  He also served on four committees for the National Academy of Sciences and Institute of Medicine.  Among the numerous awards that he received is the prestigious Paul Starr Award from the American Thyroid Association.

David S. Cooper

President, 2007

David S. Cooper, MD, MACPDavid S. Cooper, MD, MACP  David S. Cooper, MD, MACP is Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Bloomberg Johns Hopkins School of Public Health.

He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine.  He is one of the editors of the iconic textbook Werner and Ingbar’s The Thyroid and has served as a contributing editor at the Journal of the American Medical Association, Deputy Editor of the Journal of Clinical Endocrinology and Metabolism, the endocrine Editor-in-Chief for Up-to-Date, and the endocrine board chair for the Endocrine Society’s Clinical Endocrinology Update.

Dr. Cooper is the recipient of the American Thyroid Association’s Distinguished Service Award and Paul Starr Award, the Distinction in Endocrinology Award given by American Association of Clinical Endocrinologists, and the Endocrine Society’s Outstanding Scholarly Physician Award.  Dr. Cooper was the original Chair of the American Thyroid Association’s task force that drafted guidelines for the management of thyroid nodules and thyroid cancer in 2006 and 2009. He also has served on guidelines task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism.

Rebecca S. Bahn

President, 2008

Rebecca S. Bahn, MDRebecca S. Bahn, MD  Rebecca S. Bahn, MD is Professor Emeritus of Medicine at the Mayo Clinic and is recognized for her over 30 years of work on thyroid-related eye disease.  She also is the Director of the Women’s Health Research Center and Associate Dean of Research for Career Development at the Mayo Clinic.  Dr. Bahn continues to study the causes of Graves’ ophthalmopathy, Graves’ hyperthyroidism and other autoimmune thyroid diseases and has been at the forefront in developing novel therapies for the treatment and prevention of these conditions.

Dr. Bahn has served as chair of the ATA Hyperthyroidism Guidelines Task Force from 2008-2011.  She has served as the basic science program chair for the ATA Annual Meeting in 2003 as well as the ATA Program Committee representative for the International Thyroid Congress in 2001.  She has served as Editor of the ATA newsletter Signal and as Associate Editor of Thyroid.  Dr. Bahn was presented the ATA Distinguished Service Award in 2011 and is the recipient of the 2014 Woman of the Year award from ATA Women in Thyroidology.

Kenneth D. Burman

President, 2009

Kenneth D. Burman, MD, MACPKenneth D. Burman, MD, MACP  Kenneth Dale Burman, MD, MACP is Professor of Medicine in the Department of Medicine at Georgetown University, Washington, DC, Chief of the Endocrine Section and Director of the Integrated Endocrine Training Program at Georgetown University/MedStar Washington Hospital Center.  Dr. Burman completed his endocrine fellowship at Walter Reed Army Medical Center in Washington, DC before moving to the MedStar Washington Medical Center.  His research interests are focused on the molecular mechanisms underlying the progression of thyroid cancer and its application in developing novel and more specific and personalized treatments

An ATA member for over 40 years, Dr. Burman has received multiple awards, including the ATA Van Meter, Paul Starr, Stanbury and Braverman awards and the Henry Award for Lifetime Excellence in Teaching from the American College of Physicians.  He also has served on the editorial board of Thyroid and on the FDA Endocrine Advisory Board in Endocrinology and Metabolism.

Terry F. Davies

President, 2010

Terry F. Davies MD, FRCPTerry F. Davies MD, FRCP  Terry Francis Davies, MD, FRCP is the Florence and Theodore Baumritter Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York City and Director Emeritus of the Division of Endocrinology, Diabetes and Bone Diseases. Dr. Davies is also a part-time physician at the James J. Peters VA Medical Center in the Bronx, New York. Dr. Davies was trained in the UK at the Newcastle University and after further research experience at the National Institutes of Health in Bethesda, Maryland, he has spent most of his career in New York at Mount Sinai. Dr. Davies has focused his basic research efforts in the areas of immunology, cell biology and genetics as these relate to thyroid disease.  He has focused his clinical efforts in autoimmune thyroid disease (AITD) and AITD in pregnancy.

Dr. Davies is a member of the American Association of Physicians.   He was awarded the ATA John B. Stanbury Medal for Thyroid Physiology in 2010 and in 2012 he was made an Honorary Fellow of his home university in Newcastle, UK.  He also has served as the Editor-in-Chief of the journal Thyroid from 2001-2008.

Gregory A. Brent

President, 2011

Gregory A. Brent, MDGregory A. Brent, MD  Gregory A. Brent, MD is Professor of Medicine and Physiology and Chief of the Division of Endocrinology, Diabetes and Metabolism in David Geffen School of Medicine at the University of California, Los Angeles.  He is Chair of the Department of Medicine in VA Greater Los Angeles Healthcare System.  His research focus is on the molecular mechanisms of thyroid hormone action in metabolic regulation and neural differentiation, and the regulation of iodine transport in hormone-dependent cancers. He has conducted clinical research in thyroid disease in pregnancy and in chronic kidney disease patients.

He is an elected member of the American Society for Clinical Investigation and Association of American Physicians. He is past chair of the National Institutes of Health Molecular and Cellular Endocrinology Study Section and the Endocrine Merit Review Board for the Department of Veterans Affairs.  He has served on the editorial boards of Journal of Clinical Endocrinology and Metabolism, Molecular Endocrinology, Thyroid and Endocrinology.  He has been recognized with the American Thyroid Association Van Meter, Braverman, Ingbar, and Distinguished Service Awards.

James A. Fagin

President, 2012

James A. Fagin MDJames A. Fagin MD  James A. Fagin, MD is Head of the Division of Subspecialty Medicine and a Member of the Human Oncology and Pathogenesis Program (HOPP) at MSKCC, and a Professor of Medicine at the Weill Cornell Medical College of Cornell University.

After obtaining his medical degree from the University of Buenos Aires in Argentina and postgraduate training in the UK, he joined the laboratory of Dr. Shlomo Melmed at Cedars-Sinai Medical Center in Los Angeles to research pituitary tumorigenesis.  He started his own group at that institution before accepting the position of Professor and Chief of Endocrinology at the University of Cincinnati in Ohio from 1995-2006.  From 2006-2019 he was Chief of the Endocrinology Service at Memorial Sloan Kettering Cancer Center in New York.

A long-standing member of the ATA, Dr. Fagin was the recipient of the Sydney Ingbar Lectureship Award in 2008 and the John B. Stanbury Thyroid Pathophysiology Medal in 2017. The focus of his work is to understand the biology and pathogenesis of thyroid cancers with the goal of identifying new mechanism-based therapies.

Bryan R. Haugen

Bryan R. Haugen, MD, FACP 

President, 2013

Bryan R. Haugen, MD, FACP  Bryan R. Haugen, MD, FACP is Professor of Medicine and Pathology at the University of Colorado School of Medicine.  He is also Head of the Division of Endocrinology, Metabolism and Diabetes and Director of the Thyroid Tumor Program, which provides care for more than 4000 patients.  Dr Haugen is a Fellow in the American College of Physicians and a member of the Association of American Physicians.  He served as Chair of the 2015 ATA Thyroid Nodule and Differentiated Cancer Guidelines Task Force and has received the Paul Starr Award from the ATA for advancements in clinical thyroidology and the Sidney H. Ingbar Award for advancements in thyroid research over the past 25 years.  Dr. Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets.

Hossein Gharib

President, 2014

Hossein Gharib, MD, MACP, MACEHossein Gharib, MD, MACP, MACE  Hossein Gharib, MD, MACP, MACE is Professor of Medicine and Consultant in Endocrinology, Metabolism, and Diabetes at the Mayo Clinic in Rochester, Minnesota.  Born in Iran and following in the footsteps of his physician father, he completed a fellowship in endocrinology and metabolism at the Mayo Clinic where he joined the clinical staff in 1972.  He has served as an editorial board member for many journals including Thyroid, Journal of Clinical Endocrinology and Metabolism, Endocrine Practice, Acta Endocrinologica (Buc), and US Endocrinology.

Dr. Gharib joined the ATA in 1973 and, during almost five decades of membership, he has served in many leadership positions.  He is the recipient of awards from many endocrine organizations, including the ATA Paul Starr Award in 2003 and the Endocrine Society Distinguished Physician Award in 2010.  He served as President of the American Thyroid Association in 2014 and of the American Association of Clinical Endocrinologists in 2003.

Robert C. Smallridge

President, 2015

Robert C. Smallridge, MDRobert C. Smallridge, MD Robert C. Smallridge, MD is Emeritus Professor of Medicine at Mayo Medical School and Emeritus Alfred D. and Audrey M. Peterson Professor of Cancer Research.  Before he retired in 2019, Dr. Smallridge served as Deputy Director in the Mayo Clinic Cancer Center and as the Chair of the Division of Endocrinology, the Director of Research, and as a member of the Board of Governors.   Prior to joining the Mayo Clinic, Dr. Smallridge retired as Colonel after 23 years in the U.S. Army Medical Corps.  He served as the Director of the Department of Medicine at Walter Reed Army Institute of Research, as Chair of the Endocrinology Division at the Uniformed Services University of the Health Sciences, and as the Endocrinology Consultant to the Attending Physician for members of Congress.

During his more than 40 years of commitment to the ATA, Dr. Smallridge has served in multiple leadership positions and on many committees.  He chaired the clinical practice guidelines task force for anaplastic thyroid carcinoma.

Antonio Bianco

President, 2016

Antonio C. Bianco, MD, PhDAntonio C. Bianco, MD, PhD  Antonio Bianco, MD, PhD is Professor of Medicine in the Section of Endocrinology, Diabetes, and Metabolism at the University of Chicago.  A physician-scientist trained in São Paulo, Brazil, he has focused his research efforts on how the systemic hormone T3 initiates or terminates critical biological steps while maintaining relatively stable levels in the circulation.   His work has established the importance of local regulation of TH metabolism provided by deiodinases D1, D2, and D3 on a tissue-specific basis.  He has published over 260 peer-reviewed articles focused on thyroid hormone metabolism and action, with implications for the treatment of patients with hypothyroidism.

Dr. Bianco has been recognized with numerous awards and elective memberships in several professional societies, including the American Society for Clinical Investigation in 2005 and the Association of American Physicians in 2010.   He has received the Van Meter Award and the John B. Stanbury Award from the American Thyroid Association, the LATS Prize from the Latin American Thyroid Society, and the Rosalind Pitt-Rivers Medal from the British Thyroid Association.  Dr. Bianco has served as a regular member of the MCE NIH study section and the Board of Scientific Counselors of the NIDDK, and currently serves at the CSME study section. Bianco also served in different administrative capacities such as Chief of Endocrinology at the University of Miami and Rush University, where he also served as President of the Medical Practice.

John C. Morris

President, 2017

John C. Morris, III, MD John C. Morris, III, MD  John C. Morris, III, MD is Professor of Medicine at Mayo Clinic School of Medicine and past Chair of the Division of Endocrinology, Diabetes, Metabolism, and Nutrition.  He also has a joint-appointment in the Division of Medical Oncology, where he sees patients with advanced endocrine malignancies.  Since his appointment to the Mayo consulting staff, Dr. Morris has been involved in clinical practice, education, and research, with a special emphasis on thyroid disease and thyroid cancer.   He also directs research into the role of sodium-iodide symporter as a novel therapeutic gene for cancer gene therapy, applying this approach to metastatic, hormone-resistant prostate cancer.

A long-standing member of the American Thyroid Association, he has served on numerous committees and assumed many leadership roles, including Board member, Secretary/COO, and President.

Charles H. Emerson

President, 2018

Charles H. Emerson, MDCharles H. Emerson, MD  Charles H. Emerson, MD is Professor Emeritus of Medicine in the University of Massachusetts Medical School (UMASSMED).  He obtained an MD degree from the University of Virginia and, after a year of endocrine fellowship at the University of Pennsylvania in Philadelphia, he served as Chief of Endocrinology at the U.S. Army Medical Center in Augusta, Georgia.  After military service, he returned to the University of Pennsylvania to complete his endocrine fellowship and work on purifying thyroid stimulating antigen, the kinetics of thyrotropin releasing hormone (TRH), inappropriate TSH secretion, and the effects of lithium and stable iodine on thyroid function. In 1974 he moved to the University of Illinois where he worked on developing assays for TRH metabolites and an endogenous TRH antibody binding ligand in urine.  In 1980 Dr. Emerson joined UMASSMED as Professor of Medicine and focused his research on thyroid hormone metabolism in the chorion and placenta of various species.

Dr. Emerson has served on the VA Merit Board and as an ad hoc member of multiple NIH study sections.  In addition to membership in The Endocrine Society, the American Association of Clinical Endocrinologists, and the European Thyroid Association, he has been an active member of the American Thyroid Association, serving as a Board Member, Treasurer, and as ATA President. He has also served as Editor-in-Chief of Thyroid, Associate Editor of Clinical Thyroidology and Endocrine Practice, and was awarded the ATA Distinguished Service Award in 2010.

Elizabeth N. Pearce

President, 2019

Elizabeth N. Pearce, MDElizabeth N. Pearce, MD Elizabeth N. Pearce, MD is Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition.  She received her undergraduate and medical degrees from Harvard and a master’s degree in epidemiology from the Boston University School of Public Health.  She has been an active member of the American Thyroid Association and serves as the Regional Coordinator for North America for the Iodine Global Network. She has served as a Deputy Editor for the Journal of Clinical Endocrinology and Metabolism, as an Associate Editor for the journals Thyroid, Clinical Thyroidology, and Endocrine Practice, and has served on multiple additional editorial boards. She co-chaired the ATA 2017 Thyroid in Pregnancy Guidelines Task Force.

Her research interests include iodine nutrition, thyroid function in pregnancy, the thyroid effects of environmental disruptors, and the effects of subclinical thyroid dysfunction.  Dr. Pearce was the 2011 recipient of the ATA Van Meter Award for outstanding contributions to thyroid research and was the 2018 Women in Thyroidology Woman of the Year.

Martha A. Zeiger

President, 2020

Martha Zeiger, MD, FACS
Martha Zeiger, MD, FACS  Martha Zeiger, MD, FACS is an endocrine surgeon and scientist researching molecular diagnostics for thyroid cancer.  She completed her medical degree at the Robert Larner College of Medicine at the University of Vermont, her surgical training at Maine Medical Center, and her surgical oncology fellowship at the NCI/NIH.  Prior to joining academia, Dr. Zeiger spent six years in the U.S. Navy as a general medical officer, commander, and surgeon.  After her military service, Dr. Zeiger joined the Johns Hopkins School of Medicine, where she established an endocrine surgery section and served as Associate Dean for Postdoctoral Affairs. She left Johns Hopkins in 2017 to chair the Department of Surgery at the University of Virginia.  Dr. Zeiger is currently the Director of the Surgical Oncology Program at the National Cancer Institute with the National Institutes of Health.

In 2019, Dr. Zeiger received the Braverman Distinguished Award from the American Thyroid Association (ATA).  That same year, Dr. Zeiger began her term as President of the ATA and of the American Association of Endocrine Surgeons.  Her research focuses on hTERT gene expression regulation, molecular marker diagnostic panel development and molecular biological aspects of thyroid cancer development.

Victor J. Bernet

President, 2021

Victor J. Bernet, MD, FACE, FACPVictor J. Bernet, MD, FACE, FACP
Victor J. Bernet, MD, FACE, FACP is Professor of Medicine in the Mayo School of Medicine.  He received his medical degree from the University of Virginia School of Medicine and his fellowship training in Endocrinology, Diabetes and Metabolism at Walter Reed Army Medical Center in Washington, DC.   During his 21 years of service in the U.S. Army Medical Corps, he was appointed Endocrinology Consultant to the Army Surgeon General and Director of the National Capitol Consortium Army/Navy Fellowship in Endocrinology, Diabetes and Metabolism.  After retiring from the U.S. Army, Dr. Bernet moved to the Mayo Clinic in Jacksonville, Florida, where he has chaired the Division of Endocrinology.  Dr. Bernet’s main academic interests have focused on thyroid nodules, thyroid cancer, and the interpretation of unusual thyroid function test results.

Dr Bernet has served on multiple ATA committees, being the chair of several.  He has served as a member of the ATA Board of Directors, Secretary and Chief Operating Officer, and President, helping to lead the ATA through many pandemic challenges.  He is currently serving as a member of the ATA Thyroid Nodules Guidelines Task Force and is a member of the International Thyroid Oncology Group.

Peter Kopp

President, 2022

Peter Kopp, MDPeter Kopp, MD  Peter Kopp, MD, a native of Switzerland, received his medical degree from the University of Berne.  After completing his training in Internal Medicine and Endocrinology at his alma mater, he moved to Northwestern University Feinberg School of Medicine in Chicago where he served as Professor of Medicine and as acting director of the Center for Genetic Medicine (CGM).   In 2018, he returned to Switzerland to assume his current role as Professor of Medicine and Médecin Chef in the Division of Endocrinology, Diabetology and Metabolism at the University of Lausanne, Switzerland.  He also continues to hold an Adjunct Professorship at Northwestern University.

Dr. Kopp has served as the Editor-in-Chief of the journal Thyroid from 2013 to 2019 and as a member of the thyroid cancer guidelines panel of the National Comprehensive Cancer Network from 2002 to 2019.  Dr. Kopp is an author or co-author of more than 200 publications, including chapters in major textbooks such as Harrison’s Principles of Internal Medicine. He serves as a co-editor of Werner and Ingbar’s The Thyroid, the editor of the web-book Thyroid Disease Manager, and as section editor of William’s Textbook of Endocrinology.

Julie Ann Sosa

President, 2023

Julie Ann Sosa, MD, MA, FACSJulie Ann Sosa, MD, MA, FACS Julie Ann Sosa, MD, MA, FACS, born in Montreal and raised in upstate New York, received her AB at Princeton, MA at Oxford, and MD at Johns Hopkins, where she completed the Halsted residency and a fellowship.  She is the Leon Goldman MD Distinguished Professor of Surgery and Chair of the Department of Surgery at the University of California San Francisco (UCSF), where she is also Professor in the Department of Medicine and affiliated faculty for the Philip R. Lee Institute for Health Policy Studies. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer.

Dr. Sosa serves as a member of the International Thyroid Oncology Group and as a member of practice guidelines committees for the ATA, NCCN, and the American Association of Endocrine Surgeons.  For the ATA, she is currently chairing the committee responsible for writing the next iteration of differentiated thyroid cancer guidelines and has previously served on committees writing guidelines for thyroid nodules and differentiated thyroid cancer (2015) and hyperthyroidism and other causes of thyrotoxicosis (2016).  She is the Editor-in-Chief of the World Journal of Surgery and is an editor of Greenfield’s Surgery: Scientific Principles and Practice. She has been inducted as a full member in the American College of Surgeons Academy of Master Educators in 2020 and has received the ATA Lewis E. Braverman Distinguished Lectureship Award in 2017.  Dr. Sosa is the author of more than 350 peer-reviewed publications and 80 book chapters and reviews, all focused on outcomes research, health care delivery, hyperparathyroidism, and thyroid cancer. She has authored or edited 7 books.

Michael McDermott

President, 2024

Michael McDermott, MDMichael McDermott, MD is Professor of Medicine and Clinical Pharmacy at the University of Colorado Denver School of Medicine and Director of the Endocrinology and Diabetes Practice at the University of Colorado Hospital. He graduated from Tulane Medical School in 1977. His Internal Medicine Internship and Residency (1977-1980), and Endocrinology and Metabolism Fellowship (1980-1982) were completed at Fitzsimons Army Medical Center in Aurora, Colorado. He spent 20 years in the US Army during which time he was the Chief of Endocrinology at Fitzsimons (1993-1997) and served as the Endocrinology Consultant to the Surgeon General (1994-1997). He has been a member of the ATA since 1992 and has been the ATA CME Director since 2009. He served on the ATA Board of Directors 2007-2010. He was the Program Chair for the ATA annual meeting in New York in 2007 and has served on multiple ATA committees: Program Committee, Finance and Audit Committee, Publications Committee, Website Committee, Lab Services Committee, Webinar Program Committee, Development Committee, Corporate Leadership Council and ATA Centennial Task Force.